Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
Billing questions? Call: 413.540.1212
CRISIS: 413.733.6661

Drug Addiction
Resources
Basic InformationLatest News
U.S. Dentists Prescribe 37 Times More Opioids Than in England: StudyMore Than 600,000 Opioid Abusers Raising Kids in U.S.Dispensing Opioid Antidote Without a Prescription Might Save LivesNot Just Opioids: Deaths Tied to Cocaine, Meth Are Soaring, TooMany Drivers Testing Positive for Marijuana, Even With Kids in CarAnother Cost of the Opioid Epidemic: Billions of Dollars in Lost TaxesNurse Practitioners Often Restricted From Prescribing Opioid TreatmentsOpioid Overuse Can Lower Hormones to Harmful LevelsVets Who Get Opioids From VA, Medicare at Higher Overdose RiskAHA News: Opioid Crisis Brings Concerns About Heart DangersAnother Side Effect of the Opioid Crisis: Heart InfectionsU.S. Deaths From Suicide, Substance Abuse Reach Record HighOpioid Overdose Deaths Quadruple, Centered in 8 StatesKratom-Related Poisonings Are Soaring, Study FindsFDA Fell Short in Preventing Fentanyl Abuse Crisis, Report ClaimsMore Car Crashes Tied to Drivers High on OpioidsInsurers Making It Harder to Treat Opioid Addiction: StudyMeth Abuse Driving Big Spike in Syphilis CasesPoor Whites Bear the Brunt of U.S. Opioid Crisis, Studies FindOpioid OD Deaths Are Saving Lives Through TransplantationMaking OxyContin 'Tamper Proof' Helped Spread Hepatitis CAHA: Marijuana, Cocaine May Play Role in Young Americans' Rising Stroke RateAnother Opioid Scourge: Infection-Related StrokesOpioid Danger to Newborns Varies By RegionAs More Smoke Pot, Are Their Jobs at Risk?Big Pharma's Marketing to Docs Helped Trigger Opioid Crisis: StudyMore Americans Mixing Opioids With SedativesOpioids Now More Deadly for Americans Than Traffic AccidentsFatal Drug ODs Soaring Among Middle-Aged Women: CDCPostpartum Opioid Rx May Lead to Persistent Use: StudyOpioid Overdose Deaths Triple Among Teens, KidsMore Evidence That Abuse of Xanax, Valium Is on the RiseCould Pot Harm Men's Sperm?Opioids May Help Chronic Pain, But Not MuchFentanyl Now the No. 1 Opioid OD KillerNew Approach to Opioid Crisis: Supervised Heroin Injection Programs?Opioids Plus Other Drugs a Deadly Mix for Heavy UsersEven Wisdom Tooth Removal May Spur Opioid AddictionMeth, Opioid Use in Pregnancy on the RiseOpioids Increasingly Tied to Deaths of Pregnant WomenMany Drugstores Won't Dispense Opioid Antidote as RequiredAHA: Meth Use Producing Younger, Harder-to-Treat Heart Failure PatientsOver 2 Million Americans Have Hepatitis C; Opioids Help Drive SpreadMany Young Drug Abusers Not Tested for Hepatitis C, Study FindsCoffee Shop Workers on Front Lines of Opioid CrisisReports Warn of Growing Opioid Crisis Among Seniors'No Documented Reason' for 1 in 3 Outpatient Opioid Rxs: StudyStates Struggle With Onslaught of Opioid OD DeathsU.S. Deaths From Suicide, Drugs Surpass DiabetesDoctors Write Fewer Opioid Scripts After Learning of Overdose Death
Links

Insurers Making It Harder to Treat Opioid Addiction: Study

HealthDay News
by -- Robert Preidt
Updated: Feb 15th 2019

new article illustration

FRIDAY, Feb. 15, 2019 (HealthDay News) -- Insurance rules that limit access to the addiction treatment medication buprenorphine may be worsening the U.S. opioid epidemic, a new study suggests.

"Buprenorphine is a safe and effective treatment that decreases deaths due to opioids and stops heroin and other opioid use. People on buprenorphine are able to get their lives back together," said study co-author Dr. Todd Korthuis. He's chief of the addiction medicine section at Oregon Health and Science University (OHSU) in Portland.

"Medicare insurance companies are making it increasingly difficult to prescribe buprenorphine, while making it easy to prescribe opioid pain medications that contributed to the opioid epidemic," he said in an OHSU news release.

For the study, the researchers analyzed Medicare Part D prescription drug plan data and found that the growing use of pre-authorization requirements increasingly limited use of buprenorphine among Medicare beneficiaries between 2007 and 2018.

Insurers commonly use pre-authorization requirements to manage or limit access to certain drugs to control costs.

In 2007, nearly 90 percent of insurance plans offered buprenophine without restriction, but that number had shrunk to 35 percent by 2018. Over that same period, the proportion of plans that covered prescription opioids (such as OxyContin) with no restrictions ranged from 93 percent to 100 percent.

"The reasons for restrictions on buprenorphine might reflect inaccurate perceptions of drug risk, societal norms related to the stigma of addiction, or financial considerations," the authors wrote.

The findings appear in a research letter published Feb. 12 in the Journal of the American Medical Association.

Buprenorphine eases withdrawal symptoms and pain, and is one of three medicines approved by the U.S. Food and Drug Administration for treating opioid use disorder.

According to study author Daniel Hartung, "Access to buprenorphine is vital within the Medicare program because Medicare has not historically covered methadone, which is the other [anti-opioid drug] indicated for opioid use disorder." Hartung is an associate professor at OHSU/Oregon State University College of Pharmacy.

Medications such as buprenorphine are an effective way to treat opioid addiction, according to the U.S. Substance Abuse and Mental Health Services Administration.

Korthuis explained that "many people still believe that medication treatment isn't really recovery. Overwhelming scientific evidence supports that medicines like buprenorphine are far more successful and safer than abstinence-only approaches. Buprenorphine saves lives. Abstinence-based approaches don't."

More information

The U.S. Substance Abuse and Mental Health Services Administration has more on buprenorphine.